1044 Comparative proteomics of the radioresistant phenotype in head and neck cancer: Gp96 as a novel prediction marker and radio-sensitizing target for radiotherapy

A.Cheng; T.Lin; J.T.Chang; H.M.Wang; C.T.Liao

首页> 外文期刊>European Journal of Cancer Supplements >1044 Comparative proteomics of the radioresistant phenotype in head and neck cancer: Gp96 as a novel prediction marker and radio-sensitizing target for radiotherapy

【24h】

1044 Comparative proteomics of the radioresistant phenotype in head and neck cancer: Gp96 as a novel prediction marker and radio-sensitizing target for radiotherapy

机译：1044头颈部癌中放射抗性表型的比较蛋白质组学：Gp96作为新型的预测标志物和放射增敏靶标

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2009年第2期|共1页
作者
A.Cheng; T.Lin; J.T.Chang; H.M.Wang; C.T.Liao;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 1044 Comparative proteomics of the radioresistant phenotype in head and neck cancer: Gp96 as a novel prediction marker and radio-sensitizing target for radiotherapy [J] . A.Cheng, T.Lin, J.T.Chang, European Journal of Cancer Supplements . 2009,第2期

机译：1044头颈部癌中放射抗性表型的比较蛋白质组学：Gp96作为新型的预测标志物和放射增敏靶标
2. Proteomics of the radioresistant phenotype in head-and-neck cancer: Gp96 as a novel prediction marker and sensitizing target for radiotherapy. [J] . Lin TY, Chang JT, Wang HM, International Journal of Radiation Oncology, Biology, Physics . 2010,第1期

机译：头颈癌中放射抗性表型的蛋白质组学：Gp96作为放射治疗的新型预测标记和致敏靶标。
3. A Computational Approach to Discovery of Novel Mutant p53 Reactivating Molecules As Targeted Radio-Sensitizing Agents for Head and Neck Cancer [J] . Nikolaev A., Zeng L., Spencer S. A., International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：用于发现新型突变体P53重新激活分子的计算方法，作为头部和颈部癌的靶向无线电敏化剂
4. Molecular Targeting of the EGF Receptor for Repopulation Inhibition during Radiotherapy of Head and Neck Cancer [C] . Paul M. Harari, Shyhmin Huang International congress of radiation research . 2000

机译：EGF受体在头部和颈部癌症放射治疗过程中抑制的EGF受体的分子靶向
5. Image-guided adaptive radiotherapy for prostate and head-and-neck cancers. [D] . O'Daniel, Jennifer C. 2006

机译：针对前列腺癌和头颈癌的影像引导自适应放射治疗。
6. Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group Personalized Radiotherapy in Head and Neck Cancer [O] . Lars Schüttrumpf, Sebastian Marschner, Katrin Scheu, 2020

机译：头颈部鳞状细胞癌患者的明确放化疗疗法-来自临床合作小组头颈癌个性化放射治疗的未选择队列研究结果
7. A Computational Approach to Discovery of Novel Mutant p53 Reactivating Molecules As Targeted Radio-Sensitizing Agents for Head and Neck Cancer [O] . A. Nikolaev, L. Zeng, S.A. Spencer, 2018

机译：用于发现新型突变体P53重新激活分子的计算方法，作为头部和颈部癌的靶向无线电敏化剂
8. Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer. Executive Summary. Comparative Effectiveness Review, Number 20 [R] . Samson, D. J., Ratko, T. A., Rothenberg, B. M., 2010

机译：头颈部放射治疗的比较效果和安全性。执行摘要。比较效力评估，第20号

1044 Comparative proteomics of the radioresistant phenotype in head and neck cancer: Gp96 as a novel prediction marker and radio-sensitizing target for radiotherapy

著录项

相似文献

相关主题

期刊订阅